FBXW7-AS1 and neoplasm: The concurrent decrease in invasiveness, tumor vasculo-angiogenesis, and survival in the expanding tumor zones in both Panc1-CSC and U87-CSC xenograft tumors collectively support DEspR as a common receptor mechanism whose activation on different cancer cell players would facilitate contemporaneous tumor progression.